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Protein puriﬁcation typically involves expressing a recombinant gene comprising a target protein fused
to a suitable afﬁnity tag. After puriﬁcation, it is often desirable to remove the afﬁnity tag to prevent
interference with downstream functions of the target protein. This is mainly accomplished by placing a
protease site between the tag and the target protein. Typically, a small oligopeptide ‘stub’ C-terminal to
the cleavage site remains attached to the target protein due to the requirements of sequence-speciﬁc
proteases. Furthermore, steric hindrance can also limit protease efﬁciency. Here, we show that respec-
tively fusing the interacting ePDZ-b/ARVCF protein-peptide pair to the target protein and a protease
enables efﬁcient processing of a minimised sequence comprising only residues N-terminal to the
cleavage site. Interaction of the protein-peptide pair enforces proximity of the protease and its minimised
cleavage sequence, enhancing both catalysis of a sub-optimal site and overcoming steric hindrance. This
facilitates the high yield puriﬁcation of fully native target proteins without recourse to specialised pu-
riﬁcation columns.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Proteins are the workhorses of living systems, catalysing re-
actions essential for metabolism, detecting and responding to
environmental stimuli, providing structural integrity to the cell
structure and detecting pathogens among numerous other func-
tions. Many of these functions are of academic or industrial interest,
necessitating the puriﬁcation of the relevant proteins. Typically,
this is accomplished by expressing a recombinant version of the
protein of interest fused to an afﬁnity tag that enables column
puriﬁcation using an appropriate afﬁnity matrix. Whilst this pro-
cess enables routine puriﬁcation of large amounts of target protein,
the presence of the afﬁnity tag fused to the protein can interfere
with downstream applications or function [1,2]. The tag may be
removed by cleavage of a protease site placed between the target
protein and the afﬁnity tag, followed by a step to separate the
protein and afﬁnity tag. Nonetheless, most sequence-speciﬁc pro-
teases have amino acid requirements at both the N- and C-terminalg (F.J. Ghadessy), saurabh.
Inc. This is an open access article usides of the cleavage site [3], leaving a small “stub” still attached to
the protein of interest. This may be unfavourable for certain
downstream applications and in the case of therapeutic proteins, it
may raise the possibility of an immune response.
Serial chromatography puriﬁcations of cellular lysates can be
used to isolate proteins of interest based on their size, charge and
pI. However this method is often laborious, non-generic and does
not guarantee fully pure protein. Researchers have previously
developed methods to fully remove any trace of the afﬁnity tag. A
system comprising a column-immobilized mutant subtilisin which
is inactive in the absence of ﬂuoride ions, and a target protein fused
to subtilisin prodomain at its N terminus has been developed [4].
The prodomain-target protein fusion is loaded onto the mutant
subtilisin column, non-speciﬁc proteins washed off and cleavage at
the junction of the prodomain-protein of interest triggered by the
addition of ﬂuoride ions at high concentration. This method re-
quires a specialised column and results in the presence of ﬂuoride
ions in the eluate which may have to be removed prior to down-
stream applications.
Another system developed involves the fusion of the protein of
interest to a mutant intein and chitin binding domain at the C
terminus [5]. The expressed protein is bound to a chitin matrix and
the cellular proteins and debris arewashed out. Addition of a strongnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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tween the intein and the native target protein, which is eluted. This
process also requires a specialised column and results in the
presence of a strong reducing agent in the elution buffer.
The TAGzyme method from Qiagen uses aminopeptidases to
cleave off N terminal histidine tags, while preventing the cleavage
of target protein residues by using “stop points” such as glutamine.
These “stop point” containing proteins are processed by Qcyclase
which converts the N terminal glutamine into pyroglutamate. This
can then be cleaved by an aminopeptidase (pGAPase) to yield native
protein. However, the necessity for inserting genetically coded
“stop points” for most proteins, and a multi-step process necessary
for obtaining native protein leaves substantial room for
improvement.
We have therefore developed a puriﬁcation system to generate
native (i.e. completely untagged) proteins of interest (Fig. 1). This
requires expression of a fusion protein comprising the ePDZ-b af-
ﬁnity clamp domain adjacent to a sub-optimal sequence-speciﬁc
protease cleavage site (preferred residues at P1’ and P2’ are
removed) followed immediately by the protein of interest. The
cognate protease is expressed with a C-terminal tag comprising the
ARVCF peptide sequence that binds ePDZ-b very tightly (Kd < 5 nM)
[6]. Typically, the presence of methionine at the P1’ position in
addition to steric hindrance posed by the folded target protein
would render cleavage at this site sub-optimal due to compromised
protease afﬁnity. However, fusion to the interacting protein-
peptide pair enforces proximity, allowing a much faster reaction
rate by increasing the effective concentration of protease in the
vicinity of a sub-optimal cleavage site. The concept of enforced
proximity has previously been described to generate proteins with
native amino termini fromMBP fusion proteins, although these still
retained C-terminal histidine tags [7].
Here, we show that this method leads to increased amounts of
native protein and is readily transposable onto pre-existing pro-
tocols and reagents used for puriﬁcation of proteins labelled with
the ubiquitous histidine tag.
2. Materials and methods
Unless otherwise speciﬁed, all oligonucleotides used in this
work were from Integrated DNA Technologies (Singapore), chemi-
cal reagents from Sigma and SplB protease from Thermo Scientiﬁc.
His-tag puriﬁcation columns were purchased from GE Healthcare.Fig. 1. Optimising cleavage at suboptimal protease sites by enforced co-localisation.
Top schematic depicts domain structure of fusion protein comprising target of inter-
est and ePDZ-b connected by protease cleavage site with methionine at P1’ position.
Protease is expressed with C-terminal ARVCF-pep tag. Interaction of ARVCF-pep (light
magenta) with ePDZ-b (green) promotes co-localisation of protease (cyan) with sub-
optimal cleavage site (grey), resulting in cleavage and generation of target protein
with no exogenous amino acids at the N-terminus. (For interpretation of the references
to colour in this ﬁgure legend, the reader is referred to the web version of this article.)Endogenous TEV protease comprising N-terminal histidine tag and
the MPB-ENLYFQS-PH-G1VCA proteinwere gifts from the Robinson
laboratory.
2.1. Plasmid construction
Expression cassettes were made by PCR ampliﬁcation of indi-
vidual genes with oligonucleotides incorporating linker extensions
which could then be joined to other genes via Splicing by Overlap
Extension (SOE). Fusion genes were inserted into expression vector
pET22 (Kan) (pET22b with ampicillin resistance cassette replaced
with kanamycin resistance) by infusion cloning. Oligonucleotide
sequences are listed in Supporting Information (Table S1).
2.2. Protease gene constructs
SplB proteases were expressed with a protein A domain fused at
the N terminus, an SplB cleavage site “WELQ” immediately pre-
ceding the ﬁrst amino acid of the mature SplB protease, and a 6X
histidine tag followed by the ARVCF peptide at the C terminus
(protein A-GGWELQ-mature SplB-His tag-ARVCF peptide). The
protein A is removed by cleavage at the “WELQ” site for a small
minority of fusion proteins during protein expression, forming
active SplB protease, which in turn cleaves more of the fusion
protein, resulting in a rapid chain reaction yieldingmature SplB-His
tag-ARVCF peptide.
The Protein A open reading frame (ORF) was ampliﬁed using
oligonucleotides oSN684 and oSN1096. oSN1096 appends a
sequence coded as “GGSGKGGWEL” at the 3’ of protein A. SplB was
PCR-ampliﬁed with oSN1099 and oSN875. oSN875 appends a par-
tial His tag to the 3’ of SplB. oSN1099 appends a sequence com-
plementary to that of oSN1096, enabling SOE PCR of these two
amplicons to yield protein A-WELQ-SplB-partial His tag cassette.
Simultaneously, the pET22b (kan) vector was ampliﬁed by in-
verse PCR using oSN1183 and oSN1184, which have complementary
5’ ends for infusion cloning, followed by intra-plasmid infusion
cloning (Clontech), creating a vector which has the “PQPVDSWV”
coding ARVCF peptide just downstream of the XhoI site. This vector
was then linearized with NdeI/XhoI, and the fusion ORF protein A-
WELQ-SplB-partial His tag was inserted by infusion cloning
yielding protein A-WELQ-SplB-His tag-ARVCF peptide in pET22b
(Kan) vector.
The TEV-AP4 protein expression construct encoded the ORF for a
maltose binding protein (MBP)-optimal TEV cleavage site
(ENLYFQS)-TEV-GGGHHHHHHGGDSWV fusion protein. The ORF
was synthesized (Genscript) and inserted into the NdeI/XhoI sites
in pET22b vector. Note the TEV expressed incorporated the S219V
mutation to reduce autolysis [8]. The TEV protease auto-cleaves
itself from MBP after expression and is puriﬁed using the 6-
histidine tag preceding the truncated ARVCF peptide (DSWV,
indicated in bold above). The vector pRK793 [8] was used to express
histidine-tagged TEV comprising the S219V mutation.
2.3. SplB-His tag-truncated ARVCF peptide constructs
These were constructed by doing inverse PCR with the above-
mentioned protein A-WELQ-SplB-His tag-ARVCF construct using
the oligonucleotides oSN1225, 1226, 1227, 1228 and 1230 with the
common reverse oligonucleotide oSN1229 to yield constructs
expressing ARVCF peptides PQPVDSWV, QPVDSWV, PVDWSV,
VDSWV and DSWV respectively.
2.4. SplB-truncated His tag-DSWV constructs
The protein A-WELQ-SplB-truncated His tag-DSWV was created
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construct described above with oSN1396 and oSN1397 followed
by intra-plasmid infusion to truncate the number of histidines from
6 to 5.
For the construct with 4 histidines, the original protein A-
WELQ-SplB-6x His tag-DSWV ORF was ampliﬁed with oSN684 and
oSN1407, followed by infusion into a vector obtained by inverse PCR
using the oligonucleotides oSN1229 and oSN359.
2.5. ePDZ-b -WELQ-protein constructs
The ePDZ-b ORF was PCR-ampliﬁed using tandem oligonucleo-
tides oSN1344 and 1348 and reverse oligonucleotide oSN1386 to
attach a 6x histidine tag to the N terminus of ePDZ-b and a linker
coding for amino acids “WELQM” to the 3’ terminus. The ORF for
LSSmOrange (OFP) was PCR-ampliﬁed using oSN1318 and oSN1312,
followed by SOE PCR to create histidine tag-ePDZ-b-WELQ-OFP
expression cassette. This was then inserted by infusion cloning
into pET22b (Kan) vector obtained by inverse PCR using oSN359-
1384.
2.6. ePDZ-b -TEV site-protein constructs
The previously constructed ePDZ-b-WELQ-OFP plasmid was
inverse PCR-ampliﬁed with oSN1410 and oSN1315. The OFP ORF
(PCR-ampliﬁed using oSN1414-1412) was inserted into this plasmid
by infusion cloning to yield His tag-ePDZ-b-ENLYFQ-OFP. This
plasmid was subsequently PCR-ampliﬁed using primers oSN1415
and oSN1416 and the ﬁbronectin 10Fn3 domain ORF (obtained by
amplifying plasmid 10FN3-HA_pET22b with primers oSN 1417 and
1418) inserted via infusion cloning. The resulting His tag-ePDZ-b-
ENLYFQ-10Fn3 expression plasmid was subsequently ampliﬁed by
inverse PCR using primer pairs oSN1419/1420 and oSN1419/1421
and products intramolecularly ligated post-phosphorylation to
yield constructs expressing His-tag-ePDZ-b-ENLYFQ-MGGS-10Fn3
and His-tag-ePDZ-b-ENLYFQ-MGGSGGS-10Fn3 respectively.
2.7. Protein expression
All protein expressionwas carried out in E. coli BL21 (DE3) using
IPTG induction of the T7 promoter. Colonies were inoculated
overnight (ON) in 10 mL TY medium supplemented with the
appropriate antibiotic at 37 C with shaking at 180 rpm. The next
day, the cultures were diluted into 800 mL of fresh medium and
allowed to grow at 37 C to an OD600 of 0.5, upon which IPTG
(1 mM ﬁnal) was added. Induction was allowed to proceed over-
night at room temperature. The next day, cells were pelleted down
and stored at 20 C until further processing.
2.8. Protein puriﬁcation
Cell pellets obtained as described above were resuspended in
20 mL of PBS-Tween or other buffers as mentioned in the text
followed by lysis by sonication. The lysate was centrifuged at
14800 rpm for 10 min in 50 mL Falcon tubes and the supernatant
was collected. In parallel, a 1 mL FF His-trap column (GE Health-
care) was washed with 10 mL of the same buffer inwhich the pellet
was resuspended. After collecting the cell lysate supernatant, it was
run through the column, followed by washing with 10 mL of
washing buffer (the same buffer used for cell pellet resuspension).
Thereafter elution buffer (50 mM Sodium Phosphate þ 300 mM
NaCl þ 500 mM Imidazole) was run through the column and 1 mL
fractions were collected. All other fractions were also collected and
the normalized volumes of the fractions were run on an SDS-PAGE
gel followed by staining by Instant Blue for visualization.The fractions containing high concentrations of pure protein
were mixed with glycerol to a ﬁnal volume of 50% glycerol and
stored at 20 C.
2.9. Go Native protein puriﬁcation
Cell pellets were resuspended and lysed as described above. The
cell lysate was loaded on an equilibrated His-trap column followed
bywashingwith 10mL of buffer. Next, 5mL of the relevant protease
(0.5 mg/mL) was loaded on the column. The column was capped
and incubated at room temperature for the relevant duration.
Thereafter, washing buffer was run through the column and frac-
tions collected. Finally, imidazole elution buffer was run through
the column. All fractions were collected and normalized volumes
electrophoresed on an SDS-PAGE gel followed by staining with
Instant Blue.
2.10. Mass spectrometry/N-terminal protein sequencing
To elucidate cleavage sequence speciﬁcity mass spectrometry
analysis was performed. Following SDS-PAGE separation and Coo-
massie visualisation, gel band with protease cleaved product was
excised and subjected to “in-gel” digestion [9]. Following desalting,
sample was injected and separated using Orbitrap Fusion mass
spectrometer coupled to nanoUHPLC system Easy LC1000 (Thermo)
in a 45 min gradient. To generate peak list Proteome Discoverer 1.4
software was used. Searches were done using Sequest HT algorithm
against Human Uniprot database appended with speciﬁc target
sequence (87458 entries) with following parameters: precursor
mass tolerance (MS) 10 ppm, (MS/MS) IT-MS/MS 0.6 Da; no-
enzyme; 2 miss cleavages; Static modiﬁcations: Carboamido-
methyl (C), Variable modiﬁcations: Oxidation (M), Deamidated
(NQ). N-terminal sequencing of gel-puriﬁed protein [10] was car-
ried out by Biosynthesis (USA).
3. Results
We ﬁrst tested the principle using ePDZ-b fused to the target
protein (orange ﬂuorescent protein, OFP) and ARVCF peptide fused
to SplB protease (SplB-AP). SplB protease cleaves after the sequence
WELQ with methionine at the P1’ position poorly tolerated [11,12].
When combined with potential steric exclusion by the protein of
interest being puriﬁed, methionine at P1’ will pose barriers to
optimal SplB protease cleavage. The WELQ peptide sequence was
introduced between ePDZ-b and OFP. Incubation of the fusion
substrate (ePDZ-b-WELQ-OFP) with a stoichiometric excess of
either SplB-AP or commercially available SplB protease (SplB-COM)
resulted in cleavage and generation of native OFP (Fig. 2). However,
this was notably more efﬁcient for SplB-AP compared to SplB-COM
and SplB fused to a control peptide that does not interact with
ePDZ-b (SplB-CON) (compare lanes 2,6e8). Neither SplB-COM or
Spl-CON was able to completely digest the fusion substrate. The
increased efﬁciency of SplB-AP was more pronounced when it was
reduced to sub-stoichiometric levels compared to substrate (Fig. 2,
compare lanes 9, 13e15 and lanes 16, 20e22). The very high afﬁnity
between ePDZ-b and ARFCP peptide may result in prolonged
tethering of protease to ePDZ-b after cleavage of target protein. This
would reduce “turn-over” of the protease, necessitating use of
higher stoichiometric amounts. We tested this hypothesis by
reducing the afﬁnity of the ePDZ-b-ARVCF peptide interaction by
serially truncating the ARVCF peptide fused to SplB from 8 to 4
amino acids (PQPVDSWV to DSWV). At high protease concentra-
tion, no variation was observed in cleavage efﬁciency (Fig. 2, lanes
2e5). At sub-stoichiometric amounts, 3 and 4 amino acid trunca-
tions of the ARVCF peptide showed clear improvements in activity
Fig. 2. Enhanced cleavage of a target fusion protein by enforced co-localisation. Orange ﬂuorescent protein (OFP) was expressed as a fusion with ePDZ-b connected by WELQ
peptide substrate for SplB protease. 30 mg of this protein (ePDZ-b-WELQ-OFP) was incubated with varying amounts of the indicated SplB protease variants. These included SplB with
full-length ARVC-pep tag at C-terminus (SplB-PQPVDSWV) and 3 progressively shortened peptide tags. These tagged proteases all showed improved cleavage to yield native OFP
(red arrow) compared to SplB protease tagged with a non-speciﬁc C-terminal peptide (SplB-CON) and commercial non-tagged SplB protease (SplB-COM). (For interpretation of the
references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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18e19). Furthermore, the overall activity compared to the SplB-
CON and SplB-COM was signiﬁcantly enhanced (compare lanes
18e19 and 20e21).
We next applied the principle to TEV protease, one of the most
ubiquitous enzymes used to remove afﬁnity tags that optimally
cleaves the consensus sequence ENLYFQYS [13,14]. We constructed
a fusion substrate wherein this sequence was truncated to ENLYFQ,
and placed between the ePDZ-b and OFP components. TEV is able to
cleave when serine at P1’ position is replaced by methionine with
marginal loss of activity [15]. However, steric constraints due to the
tightly folded N-terminal region of OFP could impact negatively on
cleavage. The results show clearly improved cleavage when TEV is
fused to the optimised 4-amino acid truncated ARVCF peptide
(TEV-AP4) (Fig. 3A). Notable cleavage was observed after only
30 min incubation with majority of substrate beng cleaved after
2.5 h. In comparison, TEV protease only showed signiﬁcant cleavage
after 24 h incubation. Note that both the TEV-AP4 and TEV proteins
used comprise the S219A mutation introduced to reduce autolysis
[8]. A control experiment using a fusion substrate comprising the
full TEV consensus sequence (ENLYFQS) led to equivalent cleavage
by both wild-type TEV and TEV-AP4 (Fig. 3B). The endogenous TEVFig. 3. Improved cleavage of target fusion protein comprising TEV cleavage site with methi
consensus TEV recognition sequence) was incubated with either TEV protease tagged with o
(lanes 14e21) for indicated times. Native OFP (arrowed red) was rapidly generated through
Lanes 12 and 24 show TEV-AP4 and TEV proteases respectively (dotted arrows). Note both co
protein substrate MPB-ENLYFQS-PH-G1VCA with optimal TEV recognition sequence (unde
14e21) to yield S-PH-G1VCA. Lanes 12 and 24 respectively show TEV-AP4 and TEV proteases
the references to colour in this ﬁgure legend, the reader is referred to the web version of tprotease (minus the S219Vmutation) showed even poorer cleavage
when compared to TEV-AP4 for the same substrate (Fig. S1). We
next assayed TEV-AP4 on a fusion substrate where OFP was
replaced with the ﬁbronectin 10Fn3 domain (ePDZ-b-ENLYFQY-
10Fn3). As before, signiﬁcantly enhanced cleavage was obtained in
very short times when using TEV-AP4 compared to TEV (Fig. 4A).
Given the highly compact 10Fn3 fold [16], it is likely that steric
constraints inhibit cleavage by TEV. Introduction of GGS or GGSGGS
linkers (to yield ePDZ-b-ENLYFQYMGGS-10Fn3 and ePDZ-b-
ENLYFQYMGGSGGS-10Fn3 respectively) resulted in improved
cleavage by TEV, yet this was still considerably less than for TEV-
AP4 (Fig. 4B,C). As before, endogenous TEV also performed poorly
using this substrate set (Fig. S2).
We next explored whether the enforced-proximity concept was
applicable to conventional on-column cleavage and puriﬁcation
protocols using histidine tagged proteins. Complete immobilisation
of protease via its histidine tag could reduce turnover during on-
column cleavage of a co-immobilised substrate, necessitating use
of increased amounts for efﬁcient cleavage. Addition of 30 mM
imidazole alleviated this constraint, resulting in improved cleavage
efﬁciencies using histidine tagged ePDZ-b -WELQ-OFP and SplB-AP
proteins (Fig. S3). These conditions were used for the on-columnonine at P1’ position. A) The ePDZ-b-ENLYFQ-OFP fusion protein (ENLYFQ is truncated
ptimised 4 amino acid ARVC-peptide (TEV-AP4) (lanes 2e9) or untagged TEV protease
use of TEV-AP4 compared to TEV. Lanes 11 and 23 show untreated fusion substrate.
mprise the S219V autolysis resistance mutation. B) Same as in A, except using the fusion
rlined). Similar cleavage was observed for both TEV-AP4 (lanes 2e9) and TEV (lanes
(dotted arrows). Lanes 11 and 23 show untreated fusion substrate. (For interpretation of
his article.)
Fig. 3. (continued).
Fig. 4. Improved cleavage of ﬁbronectin 10Fn3 domain fusion proteins comprising TEV cleavage site with methionine at P1’ position. A) The ePDZ-b-ENLYFQ-10Fn3 fusion protein
was incubated with either TEV-AP4 (lanes 2e9) or TEV protease (lanes 14e21) for indicated times. Native 10Fn3 is arrowed red. Lanes 11 and 23 show untreated fusion substrate.
Lanes 12 and 24 show puriﬁed TEV-AP4 and TEV (dotted arrows) respectively. B) Same as in A, except using the fusion protein substrate ePDZ-b-ENLYFQ-MGGS-10Fn3. C) Same as in
A, using substrate ePDZ-b-ENLYFQ-MGGSGGS-10Fn3. Note TEV used here comprises the S219V autolysis resistance mutation. (For interpretation of the references to colour in this
ﬁgure legend, the reader is referred to the web version of this article.)
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Fig. 5. Improved on-column cleavage of a recalcitrant fusion protein substrate by TEV-
AP4. (A) The HIS-ePDZ-b-ENLYFQ-OFP fusion substrate protein and either HIS-TEV-AP4
(left gel) or HIS-TEV (right gel) were co-immobilised and on-column cleavage carried
out for 2.5 h. Lanes 2 þ 11: Bacterial cell-lysate. Lanes 3e5/12-14: non-speciﬁc proteins
eluted after three washes post loading. Lanes 6 þ 15: native OFP (highlighted by
asterisk) in ﬂow-through post protease incubation. Lanes 7 þ 16: Proteins eluted from
column post-digestion by imidazole. Lanes 9 þ 18: HIS-TEV-AP4 and HIS-TEV pro-
teases. (B) Same as in A, except using fusion protein substrate HIS-ePDZ-b-ENLYFQ-
MGGS-10Fn3 and TEV (S219V). Asterisk shows MGGS-10Fn3 protein.
H.C. Goh et al. / Protein Expression and Puriﬁcation 129 (2017) 18e24 23cleavage of histidine tagged ePDZ-b -ENLYFQ-OFP protein by his-
tidine tagged TEV-AP4. Upon elution with PBS, the yield of native
OFP was signiﬁcantly increased when histidine tagged TEV-AP4
was used compared to histidine tagged endogenous TEV (Fig. 5A,
compare lanes 6 and 15). Both mass spectrophotometry and N-
terminal sequencing analysis conﬁrmed correct cleavage by TEV-
AP4 to yield OFP with an N-terminal methionine (Figs. S4 and
S5). We also carried out on-column cleavage of the histidine tag-
ged ePDZ-b-ENLYFQYMGGS-10Fn3 substrate, this time comparing
with histidine-tagged TEV(S219V). As before, TEV-AP4 showed
improved cleavage on-column (Fig. 5B).
4. Discussion
Examples are abound in nature of proteins that have evolved to
serve as platforms to bring reactants into close proximity [17]. This
mechanism improves the afﬁnity (i.e. Km) component of catalysis,
which can often be rate limiting. An example is the Ste5 platform in
budding yeast, which serves as a platform to co-localize various
reactants, enabling faster signalling [18]. Another example is the
Cdc2 kinasewhich is directed to its targets by cyclins [19]. Similarly,
enzymes such as polymerases involved in the formation of covalent
bonds between two or more molecules need to have the ability to
bind the reactants and bring them into close proximity before
catalysis [20]. This principle has previously been described to
enhance the efﬁciency of N-degron activation by TEV and to select
for TEV variants with increased P1’ substrate tolerance in vivo
[21,22]. Here, the interacting SF3b155381424 protein domain and
human spliceosome subunit p14 were respectively tethered to the
N-degron and protease.
We have extended this concept using ePDZ-b and a minimised
ARVCF peptide pair to enhance protease cleavage for in vitro
removal of afﬁnity tags. ePDZ-b comprises a synthetic bi-domainprotein “afﬁnity clamp” evolved for high afﬁnity binding to the
ARVCF peptide [6]. Results using SplB protease indicated that
enforced proximity can overcome issues of steric hindrance arising
from the presence of a bulky hydrophobic amino acid at P1’ and/or
where the structured N-terminus of a protein can limit access of
protease to an adjacent cleavage site.Whilst TEV has been shown to
tolerate a range of amino acids at the P1’ position, we have shown
greatly improved activity when methionine is present at this po-
sition by promoting co-localisation. This result also indicates that
the ePDZ-b component of the substrate fusion protein is not
contributing to steric hindrance, as reported for other fusion part-
ners [23]. TEV activity is ~10-fold reduced at 4 C (commonly used
for prolonged on-column digestion) compared to its activity at
30 C [24]. Our data shows that cleavage to yield native proteins is
rapidly expedited by enforced co-localisation at room temperature
(~22 C). This opens up the option of incubation at temperatures
closer to the TEV optimum for shorter periods that preserve
integrity of target proteins.
In sum, we have described facile use of the ePDZ-b/ARVCF
peptide pair to optimize sub-optimal cleavage by site-speciﬁc
proteases and generate completely tag-free target proteins. We
are currently evaluating the “Go Native” concept in the context of
other commonly used proteases and afﬁnity tags to further deter-
mine its broad applicability.
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